IJ

International Journal of Infectious Diseases

International Journal of Infectious Diseases is a peer-reviewed, open access journal published monthly by the International Society for Infectious Diseases. It publishes original clinical and laboratory-based research, clinical trials, reviews, and some case reports on the epidemiology, clinical diagnosis, treatment, and control of infectious diseases, with emphasis on diseases common in under-resourced countries.

Looking to publish in International Journal of Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Infectious Diseases
Impact Factor 4.3
Quartile Q1
Open Access Type Open
ISSN 1201-9712
eISSN 1878-3511
Invitation Only No
Cost Range Article Publishing Charge (APC): USD 3,500 (excluding taxes).

Submission Instructions

International Journal of Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.

Full Length Article

Cover Letter Cover letter is required. It must confirm all authors read the Instructions to Authors, approved the submission and final version, agreed to acknowledged contributors or personal communications, and that the work is original, not under review elsewhere, and will not be republished without consent.
Abstract Structured abstract is required and must be 150–200 words. Use four paragraphs headed Objectives, Design or Methods, Results, and Conclusions, or equivalent headings suited to the paper format.
Manuscript Main text must not exceed 3500 words from the introduction through the end of the conclusion/discussion. Highlights are mandatory as a separate editable file, with 3–5 bullet points and a maximum of 85 characters per bullet.
References No more than 30 references are permitted. Cite references by number in square brackets, and list them numerically in the order first cited in the text.
Figures & Tables Up to 5 figures/tables are allowed in total. Figures require captions, tables require titles, descriptions, and footnotes, and all figure and table citations in the text must match the files provided.
Reformat to International Journal of Infectious Diseases using Livewrite Premium

Clinical Trial

Cover Letter Cover letter is required. It must confirm all authors read the Instructions to Authors, approved the submitted version, agreed to named acknowledgements or personal communications, and that the work is original, not under simultaneous consideration, and will not be republished without consent.
Abstract Abstract is required and must be structured, 150–200 words. Use four paragraphs headed objectives, design or methods, results, and conclusions, or equivalent headings. Include the clinical trial registration number at the end.
Manuscript Manuscript must not exceed 3,500 words. Highlights are mandatory and must contain 3–5 bullet points, each no more than 85 characters. Include a CONSORT flow diagram and a detailed randomization procedure.
References No more than 30 references are permitted. Use numbered citations in square brackets, and list references in the order first cited. Every in-text citation must appear in the reference list and vice versa.
Figures & Tables Up to 5 figures/tables are allowed in total. Each illustration and each table must be uploaded as a separate file; tables must be removed from the main manuscript. Provide figure captions and table titles, descriptions, footnotes, and matching in-text citations.
Reformat to International Journal of Infectious Diseases using Livewrite Premium

Review Article

Cover Letter Cover letter is required. It must confirm all authors read the Instructions to Authors, approved the submitted version, agreed to named acknowledgements or personal communications, and that the work is original, not under simultaneous consideration, and will not be republished without consent if accepted.
Abstract Abstract is required. It must be structured and 150 to 200 words. Use four paragraphs headed Objectives, Design or Methods, Results, and Conclusions, or equivalent headings appropriate to the paper format.
Manuscript Main text must be 2500 to 4000 words from introduction through conclusion/discussion. Highlights are mandatory and must contain 3 to 5 bullet points, with each bullet no more than 85 characters.
References No maximum reference count is indicated. Cite references by number in square brackets, and number the reference list in order of first appearance in the text. Every in-text citation must appear in the reference list and vice versa.
Figures & Tables One or two figures/tables may be included. Figures and tables must be cited consistently in the text and uploaded with captions or titles, descriptions, and footnotes. Each illustration and each table must be submitted as a separate file.
Reformat to International Journal of Infectious Diseases using Livewrite Premium

Letter to the Editor

Cover Letter Cover letter is required. It must confirm all authors read the Instructions to Authors, approved the submitted version, agreed to named acknowledgements or personal communications, and that the work is original, not under consideration elsewhere, and will not be republished without consent if accepted.
Abstract No abstract requirement is specified.
Manuscript Manuscript must not exceed 400 words. Content is limited to comments on papers published in the journal within the past 3 months by volume.
References Maximum 10 references. Citations must use numbered square brackets, and the reference list must be numbered in order of first appearance in the text.
Figures & Tables Maximum of one table or one figure. Figures and tables must be cited consistently with uploaded files, and tables require titles, descriptions, and footnotes while figures require captions.
Reformat to International Journal of Infectious Diseases using Livewrite Premium

Recent Publications

Corrigendum to “Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis” [International Journal of Infectious Diseases, Volume 138 (January 2024), Pages 41-45]

M. Suárez, A. Pérez-Landeiro, A. Sanjurjo, O. Lima, A. Sousa, A. López, L. Martínez-Lamas, X. Cabrera, M. Rubianes, M.T. Pérez-Rodríguez

10.1016/j.ijid.2026.108901
View Publication

Corrigendum to “Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria” [International Journal of Infectious Diseases. 2026 Jun; 167:108588]

Yao Fu, Ran Li, Genhua Mu, Chuji Cheng, Mingjing Zhao, Yan Gu, Chunmei Zhang, Yang Tao, Yuanyuan Yi, Hongyang Xu, Dan Li, Genjie Wang, Shukun Chai, Bing Dai, Yanjing Xu, Shuling Deng, Lin Dou, Zhiyu Wang, Yongli Zhang, Zhancheng Gao, Dong Zhang

10.1016/j.ijid.2026.108801
View Publication

Erratum to ``Rapid increase in serotype 4 invasive pneumococcal disease among vulnerable young male adults in Belgium (2020-2024)'' [International Journal of Infectious Diseases 163 (2026) 108216]

Lize Cuypers, Gerardo J Sanchez, Juan Paulo Herrera Avila, Reinout Naesens, Thomas Antoine-Moussiaux, Sophie Herens, Xavier Holemans, Philippe Clevenbergh, Gilles Darcis, Brice Layeux, Fabrizio Buttafuoco, Laetitia Brassinne, Henry Paridaens, Maya Hites, Katrien Lagrou, Nicolas Dauby, Stefanie Desmet

10.1016/j.ijid.2026.108817
View Publication

Evaluation of Subclinical Tuberculosis Among End-Stage Kidney Disease Patients on Hemodialysis

Tanaya Siripoon, Wiwat Chancharoenthana, Saranath Lawpoolsri, Opas Traitanon, Pattharawin Pattharanitima, Nonthiya Chaisrisiri, Supitcha Kamolratanakul, Viravarn Luvira, Weerapong Phumratanaprapin, Punnee Pitisuttithum

10.1016/j.ijid.2026.108978
View Publication

Epidemiological trends in viral CNS infections in a French university hospital from 2019 to 2024, as revealed by multiplex PCR testing of cerebrospinal fluid samples

Aurélien Aubry, Etienne Brochot, Baptiste Demey, Marie Louchet-Ducoroy, Christine Pannier, Christine Segard, Catherine Francois, Sandrine Castelain

10.1016/j.ijid.2026.108977
View Publication

Frequently asked questions

How long does it take to publish?

6 days to first decision; 37 days to decision after review; 62 days to acceptance; 3 days from acceptance to online publication

Reformat to International Journal of Infectious Diseases using Livewrite Premium

Is a cover letter required?

A covering letter is required and must state that the instructions to authors have been read by all authors, the work is original, it is not under consideration elsewhere, the submitted version has been agreed by all authors, and the paper will not be published elsewhere in the same form without written consent.

Reformat to International Journal of Infectious Diseases using Livewrite Premium

What are the publication costs?

Article Publishing Charge (APC): USD 3,500 (excluding taxes).

Reformat to International Journal of Infectious Diseases using Livewrite Premium

Research Topics

Tuberculosis Research and Epidemiology Mosquito-borne diseases and control Viral Infections and Vectors Pneumonia and Respiratory Infections Antibiotic Resistance in Bacteria SARS-CoV-2 and COVID-19 Research Respiratory viral infections research Hepatitis B Virus Studies Mycobacterium research and diagnosis COVID-19 Clinical Research Studies Influenza Virus Research Studies Hepatitis C virus research Viral Infections and Outbreaks Research Antibiotic Use and Resistance COVID-19 epidemiological studies Viral gastroenteritis research and epidemiology Vaccine Coverage and Hesitancy Bacterial Identification and Susceptibility Testing Antimicrobial Resistance in Staphylococcus Pneumocystis jirovecii pneumonia detection and treatment HIV/AIDS Research and Interventions Malaria Research and Control Antifungal resistance and susceptibility Streptococcal Infections and Treatments Bacterial Infections and Vaccines

Related Journals

JO
Journal of Affective Disorders Elsevier BV
CC
Clinical Colorectal Cancer Elsevier BV
TJ
The Journal of Sexual Medicine Elsevier BV
BJ
Brazilian Journal of Physical Therapy Elsevier BV
ID
Infectious Diseases and Therapy Adis, Springer Healthcare
SI
Seminars in Diagnostic Pathology Elsevier BV